Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors

التفاصيل البيبلوغرافية
العنوان: Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors
المؤلفون: Suresh Babu Katragadda, Vinay Pogaku, Kiran Kumar Tatapudi, Srinivas Basavoju, Kiran Gangarapu
المصدر: Bioorganic chemistry. 93
سنة النشر: 2019
مصطلحات موضوعية: In silico, Molecular Conformation, Pyrazole, Crystallography, X-Ray, 01 natural sciences, Biochemistry, Anti hyperglycemic, chemistry.chemical_compound, Structure-Activity Relationship, Catalytic Domain, Drug Discovery, medicine, Humans, Hypoglycemic Agents, Glycoside Hydrolase Inhibitors, Molecular Biology, IC50, Acarbose, ADME, chemistry.chemical_classification, Binding Sites, 010405 organic chemistry, Chemistry, Organic Chemistry, alpha-Glucosidases, Combinatorial chemistry, 0104 chemical sciences, Molecular Docking Simulation, 010404 medicinal & biomolecular chemistry, Enzyme, Design synthesis, Purines, Drug Design, Pyrazoles, Caco-2 Cells, medicine.drug, Half-Life
الوصف: The aim of the present study is to design and synthesis of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors. The target compounds 4a-n were synthesized by one-pot multicomponent approach with good yields and were characterized by various spectroscopic techniques and finally by single crystal X-ray diffraction method (4j). All the newly-synthesized derivatives have been screened for their α-glucosidase enzyme inhibition activity and acarbose taken as a standard drug. Among all the tested compounds, 4h has displayed excellent α-glucosidase enzyme inhibition activity with IC50 value 12.45 μM to the standard drug acarbose (IC50: 12.68 μM). Similarly, the compounds 4f and 4l have exhibited potent activity with IC50 values 14.47 μM and 17.27 μM respectively. Structure-activity relationship (SAR) studies of all the title compounds were established. The mode of binding interactions between the α-glucosidase enzyme and the compounds were studied. The drug-likeness properties (Lipinski parameters and in silico ADME properties) have predicted for the target compounds. The α-glucosidase inhibition, molecular docking and drug-likeness properties of the compounds 4h, 4f and 4l were suggested that these are promising hits for anti-diabetic activity.
تدمد: 1090-2120
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4fd8681f5b0adde380b0cbb4fe44c15
https://pubmed.ncbi.nlm.nih.gov/31585262
حقوق: CLOSED
رقم الأكسشن: edsair.doi.dedup.....c4fd8681f5b0adde380b0cbb4fe44c15
قاعدة البيانات: OpenAIRE